LGALS9 and neoplasm: Notably, TAMs had putative interactions with tumor‐infiltrating T cells through CD80/CD86‐CTLA4, PDL1/PDL2‐PD1, and LGALS9‐HAVCR2 (Figure 4B), suggesting their immunosuppressive capability on T cells.